Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP
- PMID: 2548072
Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP
Abstract
Aminoaciduria and secondary hyperparathyroidism accompany vitamin D deficiency. However, the degree of aminoaciduria and PTH elevation have not been studied relative to different calcium and phosphorus dietary intakes. Weanling rats were fed 5 vitamin D deficient diets for 4-6 weeks: very low Ca (VLC) 0.02% Ca, 0.3% P; VLC + 1,25-dihydroxyvitamin D [1,25(OH)2D3], same + 500 pmol i.p. for 2 days; low Ca (LC) 0.45% Ca, 0.3% P; very low P (VLP) 1.2% Ca, 0.1% P; high Ca (HC) 2.5% Ca, 0.3% P, and control 1.2% Ca, 0.70% P + 2.5 micrograms% vitamin D. Amino acids, serum 25-hydroxyvitamin D [25(OH)D3], 1,25(OH)2D3, and PTH, using a specific antirat PTH antibody, were measured. A significant generalized aminoaciduria (11 amino acids) was found in all vitamin D-deficient groups. Furthermore, it was independent of plasma Ca and PTH, and urinary cAMP excretion irrespective of diet. Serum 25(OH)D and 1,25(OH)2D were significantly reduced in all vitamin D-deficient groups. VLC and VLC + 1,25(OH)2D3 were associated with the highest PTH levels (10- and 13-fold increase, respectively) and urinary cAMP (2.3-fold increase in each) and the lowest serum Ca. LC rats had an 8.8- and a 1.7-fold increase in PTH and urinary cAMP, respectively. Phosphate depletion was found in VLP rats documented by insignificantly elevated PTH, normal urinary cAMP, hypercalciuria, and percent tubular reabsorption of phosphate of greater than 99%. While dietary Ca and P affect plasma and urinary Ca and P plasma PTH and urinary cAMP, it appears that dietary P affects the aminoaciduria observed in this study via mechanisms that remain unclear. The possibility that the mechanism for the tubulopathy is multifactorial should be entertained.
Similar articles
-
Effect of vitamin D deficiency on amino acid excretion in the phosphate-depleted rat.Miner Electrolyte Metab. 1989;15(5):283-90. Miner Electrolyte Metab. 1989. PMID: 2811786
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Normocalcemia without hyperparathyroidism in vitamin D-deficient rats.J Bone Miner Res. 1991 Mar;6(3):273-8. doi: 10.1002/jbmr.5650060309. J Bone Miner Res. 1991. PMID: 2035354
-
Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.J Clin Invest. 1979 Mar;63(3):371-7. doi: 10.1172/JCI109312. J Clin Invest. 1979. PMID: 34630 Free PMC article.
-
Vitamin D physiology.Prog Biophys Mol Biol. 2006 Sep;92(1):4-8. doi: 10.1016/j.pbiomolbio.2006.02.016. Epub 2006 Feb 28. Prog Biophys Mol Biol. 2006. PMID: 16563471 Review.
Cited by
-
Renal amino acid transport: cellular and molecular events from clearance studies to frog eggs.Pediatr Nephrol. 1993 Oct;7(5):574-84. doi: 10.1007/BF00852553. Pediatr Nephrol. 1993. PMID: 8251325 Review.
-
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene.Front Endocrinol (Lausanne). 2025 Mar 28;16:1553032. doi: 10.3389/fendo.2025.1553032. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40225330 Free PMC article.
-
Interactions of vitamin D and the proximal tubule.Pediatr Nephrol. 2016 Jan;31(1):7-14. doi: 10.1007/s00467-015-3050-5. Epub 2015 Jan 25. Pediatr Nephrol. 2016. PMID: 25618772 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical